GlassScriptPhysician profile
Julia Thomas Elpers
NPI 1528419306
$2,723.83
in general payments reported to CMS, 2019-2025
13 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $121 · 2021: $589 · 2022: $129 · 2023: $226 · 2024: $708 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $688.70 | 2020-2023 | Tepezza |
| Amgen INC. | $625.46 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $295.42 | 2019-2025 | Hydrus Microstent |
| Tarsus Pharmaceuticals, INC. | $234.84 | 2024-2025 | Xdemvy |
| Halozyme INC | $170.53 | 2023-2025 | Hylenex Recombinant |
| Harrow Eye, LLC | $149.80 | 2025 | Vevye |
| Genentech, INC. | $122.38 | 2021 | |
| Aerie Pharmaceuticals, INC. | $116.53 | 2021 | |
| Abbvie INC. | $113.41 | 2024 | |
| Axogen | $101.21 | 2021 | |
| Apellis Pharmaceuticals, INC. | $53.78 | 2024-2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $30.89 | 2025 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $20.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Elpers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.